Cargando…
The Interaction of Classical Complement Component C1 with Parasite and Host Calreticulin Mediates Trypanosoma cruzi Infection of Human Placenta
BACKGROUND: 9 million people are infected with Trypanosoma cruzi in Latin America, plus more than 300,000 in the United States, Canada, Europe, Australia, and Japan. Approximately 30% of infected individuals develop circulatory or digestive pathology. While in underdeveloped countries transmission i...
Autores principales: | Castillo, Christian, Ramírez, Galia, Valck, Carolina, Aguilar, Lorena, Maldonado, Ismael, Rosas, Carlos, Galanti, Norbel, Kemmerling, Ulrike, Ferreira, Arturo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749977/ https://www.ncbi.nlm.nih.gov/pubmed/23991234 http://dx.doi.org/10.1371/journal.pntd.0002376 |
Ejemplares similares
-
Antiangiogenic and Antitumor Effects of Trypanosoma cruzi Calreticulin
por: López, Nandy C., et al.
Publicado: (2010) -
Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin
por: Ramírez-Toloza, Galia, et al.
Publicado: (2017) -
Is it all That Bad When Living with an Intracellular Protozoan? The Role of Trypanosoma cruzi Calreticulin in Angiogenesis and Tumor Growth
por: Ramírez-Toloza, Galia, et al.
Publicado: (2015) -
The Interactions of Parasite Calreticulin With Initial Complement Components: Consequences in Immunity and Virulence
por: Ramírez-Toloza, Galia, et al.
Publicado: (2020) -
Does native Trypanosoma cruzi calreticulin mediate growth inhibition of a mammary tumor during infection?
por: Abello-Cáceres, Paula, et al.
Publicado: (2016)